Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cells

Jessica Bullenkamp1, Joop Gäken, Frederic Festy

  • 1Department of Molecular Oncology, King's College London, Guy's Campus, Hodgkin Building, London, SE1 1UL, UK.

Insights

Apoptin protein triggers tumor cell death by interacting with Protein Kinase C beta (PKCβ). This interaction activates PKCβ, which then phosphorylates Apoptin, driving its nuclear translocation and anti-cancer activity specifically in tumor cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Virology

Background:

  • Apoptin, a protein from chicken anemia virus (CAV), exhibits tumor-specific cell death induction, making it a potential anti-cancer therapeutic.
  • Apoptin's cytotoxic activity relies on phosphorylation and nuclear translocation, which occurs in tumor cells but not normal cells.
  • Protein Kinase C beta (PKCβ) has been identified as a kinase that phosphorylates Apoptin in multiple myeloma cells, but the interaction mechanism is unclear.

Purpose of the Study:

  • To investigate the physical and functional link between PKCβ and Apoptin from CAV and human Gyrovirus (HGyV).
  • To elucidate the cancer-specific mechanism of Apoptin activation and its interaction with PKCβI.

Main Methods:

  • Co-immunoprecipitation and proximity ligation assays to detect protein-protein interactions.
  • Apoptin deletion constructs to identify interaction domains.
  • Förster Resonance Energy Transfer (FRET)-based PKC activity reporter assays using fluorescence lifetime imaging microscopy (FLIM).

Main Results:

  • Both CAV-Apoptin and HGyV-Apoptin bind to PKCβI in HCT116 colorectal cancer cells, with the N-terminal domain of Apoptin being crucial for this interaction.
  • Normal colon mucosa cells express lower levels of PKCβI, showing reduced Apoptin phosphorylation, nuclear translocation, and cytotoxic activity compared to cancer cells.
  • Apoptin expression significantly increases PKC activity in cancer cells but not in normal cells, indicating a cancer-specific activation pathway.

Conclusions:

  • A novel, cancer-specific interplay between Apoptin and PKCβI has been demonstrated.
  • Direct interaction between Apoptin and PKCβI leads to Apoptin-induced PKC activation.
  • Activated PKCβI mediates Apoptin phosphorylation, promoting its nuclear translocation and subsequent tumor-specific cytotoxic function.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K